BioSpace Names Most Promising New Biopharma Companies to Watch in 2024
2024-01-03
临床1期蛋白降解靶向嵌合体
DES MOINES, Iowa, Jan. 3, 2024 /PRNewswire/ -- BioSpace, the leading life sciences news and careers site, has announced its 2024 selections for the industry's most promising up-and-coming companies.
The NextGen Class of 2024 list showcases 30 innovative organizations demonstrating exciting potential. This is the 10th year BioSpace has highlighted the most anticipated new biopharma companies from across the U.S.
Topping the NextGen Class of 2024 is Rapport Therapeutics, having secured $100 million in its Series A and another $150 million in Series B funding six months later. Rapport's first program focuses on targeting drug-resistant seizure disorders and is in Phase I development.
BioSpace considers organizations across all therapeutic areas. Other top winners include Apogee Therapeutics, CARGO Therapeutics, Aera Therapeutics and Nido Biosciences.
"Despite the challenges of the macroeconomic environment of 2023, we are thrilled to highlight innovation that is still thriving across our industry," said BioSpace CEO Josh Goodwin. "It is a testament to biopharma's commitment to advancing global health, perseverance and creativity, and we are proud to showcase these companies."
BioSpace's editorial team analyzed multiple factors: financing, collaborations, pipeline, growth potential and innovation. This year's list includes top-scoring organizations that launched with Series A funding between September 2022 and September 2023.
View complete NextGen lists from previous years: Class of 2015, Class of 2016, Class of 2017, Class of 2018, Class of 2019, Class of 2020, Class of 2021, Class of 2022, Class of 2023.
NextGen Bio "Class of 2024" list
Rapport Therapeutics, Apogee Therapeutics, CARGO Therapeutics, Aera Therapeutics, Nido Biosciences, ReNAgade Therapeutics, Orbital Therapeutics, Abdera Therapeutics, SonoThera, Bitterroot Bio, Convergent Therapeutics, Ascidian Therapeutics, Delve Bio, Alterome Therapeutics, LinusBio, Actio Biosciences, i2o Therapeutics, Initial Therapeutics, Entact Bio, Rezo Therapeutics, Aether Bio, Belharra Therapeutics, Kate Therapeutics, Cajal Neuroscience, Matchpoint Therapeutics, Bonum Therapeutics, Juvena Therapeutics, Georgiamune, Nested Therapeutics, Crossbow Therapeutics.
About BioSpace
BioSpace provides essential insights, opportunities and tools to connect innovative life sciences organizations and talented professionals who advance health and quality of life across the globe. BioSpace is the leading source for careers and news for life sciences professionals in the United States.
SOURCE BioSpace
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。